Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)

Bai Liang He, Ning Yang, Cheuk Him Man, Nelson Ka Lam Ng, Chae Yin Cher, Ho Ching Leung, Leo Lai Hok Kan, Bowie Yik Ling Cheng, Stephen Sze Yuen Lam, Michelle Lu Lu Wang, Chun Xiao Zhang, Hin Kwok, Grace Cheng, Rakesh Sharma, Alvin Chun Hang Ma, Chi Wai Eric So, Yok Lam Kwong, Anskar Yu Hung Leung

Research output: Journal article publicationComment/debate/erratumAcademic research

Original languageEnglish
Article numbere12911
JournalEMBO Molecular Medicine
Volume12
Issue number8
DOIs
Publication statusPublished - 7 Aug 2020

ASJC Scopus subject areas

  • Molecular Medicine

Cite this